Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1988;12:287-294

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roman, R. J.
Right arrow Articles by Nasjletti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roman, R. J.
Right arrow Articles by Nasjletti, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*SODIUM
*SODIUM CHLORIDE

Hypertension, Vol 12, 287-294, Copyright © 1988 by American Heart Association


ARTICLES

Influence of eicosanoids on renal function of DOCA-salt hypertensive rats

RJ Roman, ML Kaldunski, DL Mattson, M Mistry and A Nasjletti
Department of Physiology, Medical College of Wisconsin, Milwaukee 53226.

The present study examined the contribution of changes in the synthesis or degradation (or both) of renal eicosanoids to the alterations in renal hemodynamics observed in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Renal blood flow and glomerular filtration rate were markedly reduced in DOCA-salt hypertensive rats compared with values observed in control rats given water or saline to drink. The abnormalities in renal hemodynamics in the hypertensive rats were associated with an increase in the excretion of thromboxane B2, an increase in the release of thromboxane B2 from renal cortical tissue slices, and a diminished release of prostaglandin E2 (PGE2) from renal medullary tissue. Additionally, the urinary excretion of PGE2 and 6- keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) and the release of 6- keto-PGF1 alpha from renal cortical and medullary tissue were elevated in rats with DOCA-salt hypertension. Since the excretion of PGE2 and 6- keto-PGF1 alpha and the release of 6-keto-PGF1 alpha by medullary tissue were also elevated in normotensive rats given 1% NaCl solution to drink, these latter changes probably were related to an elevation of sodium intake rather than to the development of hypertension. The functional significance of the alterations in the renal production of thromboxane in DOCA-salt hypertensive rats was evaluated by comparing the effects of a thromboxane synthesis inhibitor and a receptor antagonist on renal function in normotensive and DOCA-salt hypertensive rats. The administration of the thromboxane synthetase inhibitor furegrelate and the thromboxane receptor blocker SQ 29548 had no effect on renal hemodynamics in either group.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. K. Johnson, W. Durante, K. J. Peyton, and R. A. Johnson
Heme oxygenase-mediated endothelial dysfunction in DOCA-salt, but not in spontaneously hypertensive, rat arterioles
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1681 - H1687.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. H. Kim, W. B. Kim, and M. G. Lee
Pharmacokinetic Changes of a New Carbapenem, , after Intravenous Administration to Spontaneously Hypertensive Rats and Deoxycorticosterone Acetate-Salt-Induced Hypertensive Rats
Drug Metab. Dispos., June 1, 1999; 27(6): 710 - 716.
[Abstract] [Full Text]


Home page
HypertensionHome page
V. Gross, A. Lippoldt, C. Yagil, Y. Yagil, and F. C. Luft
Pressure Natriuresis in Salt-Sensitive and Salt-Resistant Sabra Rats
Hypertension, June 1, 1997; 29(6): 1252 - 1259.
[Abstract] [Full Text]